echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > ASCO2021: Follow the data, eliminate prejudice, and prevent lung cancer in action

    ASCO2021: Follow the data, eliminate prejudice, and prevent lung cancer in action

    • Last Update: 2021-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Lung cancer is an adult lung disease, not a disease caused by adult smoking


    Lung cancer is an adult lung disease, not a disease caused by adult smoking


    The number of deaths from lung cancer far exceeds that of any other type of cancer


    It is estimated that the diagnosis of lung cancer patients have a diagnosis 10% to 20% had never smoked


    Researchers and clinicians have begun to pay attention to the unique biology of lung cancer and related treatments for patients with little or no smoking history


    Early clinical experience testing EGFR inhibitors helped researchers and clinicians begin to understand pathobiology and the role of mutant oncogenes in lung cancer


    Since the discovery of EGFR mutations, many other oncogenes have been identified and incorporated into the diagnostic evaluation and management of lung cancer


    The early experience of disproportionately detecting operable oncogenes in tumors from women, people who have never smoked, and patients with lung adenocarcinoma has left many oncologists with residual biases in molecular testing based on the clinical characteristics of patients


    In 2013 , the US Preventive Services Task Force recommended for the first time low-dose CT screening


    Recently, the results of the first large-scale prospective screening study for non-smokers are as follows : TALENT ( Taiwan Non-Smoking Lung Cancer Screening Trial ) recruited more than 12,000 non-smokers or light cigarettes ( less than 10 pack years and no smoking for more than 15 years) Year ) participants, participants must also have an additional risk factor for lung cancer


    In March 2021 , the US Preventive Services Task Force updated the annual lung cancer screening recommendations for those 50 years of age or older ( previously 55 years old ) , 20 packs / year smoking history ( previously 30 packs / year ) , and quit smoking for more than 15 years


    Eliminate stigma prejudice to the elimination of prejudice to the stigma

    We can save lives through tobacco abuse prevention and smoking cessation education .


    We can abuse prevention education and cessation of tobacco prevention and cessation of tobacco abuse education to save lives


    We can save lives through lung cancer screening .


    We can use a comprehensive lung cancer mutation map for personalized treatment.


    We can abide by the oath of being a doctor, follow the data, eliminate prejudice, follow the data, eliminate prejudice


    Through our actions, we can correct this shame
    .


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.